Regencell Bioscience Holdings Limited (NASDAQ:RGC - Get Free Report) shares gapped up prior to trading on Wednesday . The stock had previously closed at $13.70, but opened at $14.50. Regencell Bioscience shares last traded at $14.23, with a volume of 447,000 shares trading hands.
Regencell Bioscience Trading Down 2.4%
Hedge Funds Weigh In On Regencell Bioscience
An institutional investor recently bought a new position in Regencell Bioscience stock. Greenfield Savings Bank acquired a new stake in shares of Regencell Bioscience Holdings Limited (NASDAQ:RGC - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,000 shares of the company's stock, valued at approximately $187,000. Hedge funds and other institutional investors own 0.13% of the company's stock.
About Regencell Bioscience
(
Get Free Report)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
See Also
Before you consider Regencell Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.
While Regencell Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
